Mednet Logo
SpecialtiesEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?

2
1 Answers

Mednet Member
Mednet Member
Ophthalmology · Jackson Eye Associates

A week or two after completion unless having an issue.

Do you temporarily hold diuretics when measuring 24-hour urine calcium levels in the evaluation of primary hyperparathyroidism?

3 Answers

Mednet Member
Mednet Member
Nephrology · University of Chicago Medicine

It is mandatory to stop diuretics at least 2 weeks before evaluating a patient for PHPT. One should have a fasting blood sample on the morning of the end of the collection for calcium phosphate and PTH to complement the urine collection. Thiazide-type diuretics raise serum calcium and lower urine ca...

Would you start romosozumab in an active smoker?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

This is not simple! But we are good at assessment of risk vs benefit (or benefit vs risk!)First I would reassess fracture risk, prior treatments, reason to consider romo. Then I would do a deep dive into risk assessment for cardiovascular disease: how much do they smoke, prior cardiovascular disease...

How is your office streamlining the administrative process for eligible Medicare patients attempting to participate in the Bridge Program for GLP-1 agonists that started July 1st?

1 Answers

Mednet Member
Mednet Member
Primary Care · VCU Medical Center

As an obesity medicine practice, we are very fortunate to have hired our own pharmacist to manage dose titrations, and she has helped to ensure a smooth transition to the Bridge Program. Additionally, I created an Epic SmartPhrase to guide everyone as to the specific exclusions, BMI requirements, an...

What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?

2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

At this point, I believe one can use either saline or lactated Ringer's. There is some evidence that low-chloride-containing solutions have advantages in general, which may well be the case, but we need more data on that. The amount of calcium in LR is very small and should not make a difference (1....

What is the preferred first-line non-insulin agent in patients with ketosis-prone diabetes during "remission" and evidence of preserved beta cell function?

2 Answers

Mednet Member
Mednet Member
Endocrinology · Texas Diabetes And Endocrinology Pa

Ketosis-prone diabetes (KPD) is an atypical form of diabetes that has been found in various racial and ethnic groups (Asian Indian, South American, West African, African American and others). People with KPD may present with DKA without the autoimmune findings of Type 1 diabetes. After the DKA episo...

Should GLP1 R agonist therapy be offered to women at high risk for breast cancer given recent data showing protective benefits?

2 Answers

Mednet Member
Mednet Member
Endocrinology · Michigan State University College of Human Medicine

Obesity is a key modifiable risk factor for breast cancer. While it is true that some observational studies have suggested that the use of GLP-1 RA is associated with a lower incidence of breast cancer (McDonald et al., PMID 42227662), this is an association. The authors of this study correctly poin...

Which other GLP-1 R agonist, if any, would you consider re-trialing in patients who had severe gastrointestinal side effects with Ozempic?

2 Answers

Mednet Member
Mednet Member
Endocrinology · Beth Israel Deaconess Medical Center Division Of Endocrinology

I am curious if you mean someone who has not tolerated the lowest dose of Ozempic, or higher doses. I have had patients who have not tolerated semaglutide but who can tolerate tirzepatide (or dulaglutide or even liraglutide if a daily injection is OK). I have also used "click counting," which is uni...

In postmenopausal osteoporosis, would you switch to romosozumab (rather than a PTH/PTHrP analog) if a patient fractures while on denosumab?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Langone

This is an interesting question because it raises the subject of how one defines "treatment failure" among patients who are using bone-strengthening medications. I remind patients that our drugs are most effective at preventing spinal fractures with efficacy that can exceed 70% relative risk reducti...

What is your approach to patients with persistent low libido despite normal testosterone levels after use of exogenous testosterone replacement therapy?

1
1 Answers

Mednet Member
Mednet Member
Urology · UCLA

The key point is understanding a man’s mental health and relationship status. I will always screen for depression and strongly encourage sex therapy. My unvalidated but effective screening question is asking when their last vacation was and how their libido and erections were. It’s surprising how ma...